Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Outset Medical (OM) Interest Expenses (2019 - 2026)

Outset Medical has reported Interest Expenses over the past 7 years, most recently at $3.4 million for Q4 2025.

  • Quarterly Interest Expenses fell 40.93% to $3.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.0 million through Dec 2025, down 41.55% year-over-year, with the annual reading at $14.0 million for FY2025, 41.55% down from the prior year.
  • Interest Expenses was $3.4 million for Q4 2025 at Outset Medical, down from $3.5 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $6.1 million in Q3 2024 and troughed at $422000.0 in Q1 2021.
  • The 5-year median for Interest Expenses is $3.2 million (2023), against an average of $2.8 million.
  • Year-over-year, Interest Expenses crashed 58.24% in 2021 and then soared 597.16% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $431000.0 in 2021, then skyrocketed by 386.31% to $2.1 million in 2022, then skyrocketed by 63.02% to $3.4 million in 2023, then surged by 70.47% to $5.8 million in 2024, then tumbled by 40.93% to $3.4 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Interest Expenses are $3.4 million (Q4 2025), $3.5 million (Q3 2025), and $3.5 million (Q2 2025).